gadolinium compound P760: Clinical Trials

3 trials of gadolinium compound P760, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Terminated 1

Follow gadolinium compound P760: new trials by email Literature Review of gadolinium compound P760 trials Research Report on gadolinium compound P760

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving the Concentration of MR Contrast in the Arteries
Standard Injection Rate, Patient Tailored Injection Rate, gadolinium contrast - Magnetic Resonance Angiography, Contrast Media
Not applicableCompletedUniversity of Washington262014-06-012017-10-26
Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies
regadenoson, Optimark®, Myocardial perfusion MRI - Coronary Artery Disease, CAD
Not applicableCompletedDaniel S. Berman442014-05-162018-08-20
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Magnetic resonance imaging, Gadolinium contrast - Neurofibromatosis Type 1
Not applicableTerminatedWashington University School of Medicine292013-04-162019-09-03

Conditions studied

Coronary Artery Disease (1)  ·  Neurofibromatosis 1 (1)

Sponsors

Daniel S. Berman (1)  ·  University of Washington (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)

Top investigators

Daniel S Berman, MD (1)  ·  David Gutmann, M.D., Ph.D. (1)  ·  Jeffrey H. Maki, MD, PhD (1)

Results publications

PMID 27149390